Autifony Therapeutics

Autifony Therapeutics is a pioneering biotechnology company focused on the research and development of innovative medicines. With a dedication to addressing unmet medical needs, Autifony Therapeutics leverages its cutting-edge ion channel drug discovery platform to create novel treatments for rare genetic Central Nervous System (CNS) disorders.

Based in Stevenage Bioscience Catalyst, Stevenage, SG1 2FX, GB, Autifony Therapeutics operates as a privately held entity committed to advancing healthcare through groundbreaking scientific discoveries. Autifony Therapeutics is dedicated to improving patient outcomes by translating advanced research into effective therapeutic solutions.

Autifony Therapeutics' commitment to excellence drives its pursuit of innovative therapies. We look forward to sharing more about Autifony Therapeutics and its ongoing advancements in the biotechnology field, with details to be completed soon with the support of the company’s management.

To the manager of Autifony Therapeutics, we invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight your achievements and connect with a wider audience.